To explore YKL-40’s potential role as a prognostic biomarker of breast cancer patients, we next analyzed the associations of patients’ characteristics with mean serum concentrations in the patients stratified by the status of YKL-40 intratumoral staining (Table 1). The gene discussed is CHI3L1; the disease is breast carcinoma.